Preoperative evaluation of future remnant liver function by the contrast enhance ratio in hepatocellular image.



Similar documents
Utilization management for successful process optimization in radiology

OA related pain medication intake in subjects from the OAI incidence cohort - association with focal knee lesions and cartilage T2 measurements

CT findings in Differential Diagnosis between Tuberculous Pleurisy and Malignant Effusion

Patterns of nodal spread in thoracic malignancies

Eye lens dose measurements in Interventional Cardiology

An Image Based Semiautomatic Online Cancer Staging Program for Common Female Pelvic Malignancies

Development and implementation of a help desk system in a radiology department in a high complexity hospital: a South American experience

Pancreatic masses: What is there besides cancer

Diffuse infiltration in multiple myeloma treatment response assessment with "total-spine" contrast enhanced MR imaging

MRI scanning of the claustrophobic patients

Determination of bone age using MRI of hand/wrist: a pilot study

Normal vascular variants of the upper extremity

Comparison of radiation dose from X-ray, CT, and PET/ CT in paediatric patients with neuroblastoma using a dose monitoring program

DICOM metadata-mining in PACS for computed radiography X-Ray exposure analysis: a mammography multisite study

Acute abdominal pain in the elderly patient: Impact of early MDCT examination on diagnosis and management

Needle crystal detector technology in mammography further dose reduction and clinical image quality with

Role of 3D volumetry CT in the correlation between postoperative gastric volume and weight loss in obese patients undergoing gastric sleeve surgery.

MR imaging of primary sclerosing cholangitis (PSC) using the hepatobiliary specific contrast agent Gd-EOB-DTPA

Metastatic malignant melanoma revisited

Comparison between photoacoustic mammography images of breasts cancers and histological staining patterns of CD31 and carbonic anhydrase IX

Angio-CT preoperative planning of inferior limb free flaps in plastic surgery

Differential diagnosis of vertebral compression fracture using in-phase/opposed-phase and Short TI inversion recovery imaging

Second look ultrasound examination for breast lesions: MRI and pathologic correlation

Abdominal CT Perfusion: Effects of Breath Control Technique

Diagnostic performance of MRI in differentiating metastatic from acute osteoporotic compression fractures of the spine

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

LIVER FUNCTION TESTS

The State of the Liver in the Adult Patient after Fontan Palliation

LIVER CANCER AND TUMOURS

Respiratory dynamic MRI for determining aortic invasion of thoracic neoplasms

Albumin. Prothrombin time. Total protein

Physician Quality Reporting System (PQRS)

Using Indocyanine Green Test to Avoid Post-hepatectomy Liver Dysfunction

Patterns of abnormal LFTs and their differential diagnosis

Visual Acuity. Hearing. Height and Weight. Blood Pressure MEASURED VALUE

Hepatocellular Carcinoma (HCC)

Approach to Abnormal Liver Tests

Clinical Practice Guidelines for Hepatocellular Carcinoma, List of Clinical Questions/Recommendations. Chapter. Grade. CQ No. 1 Interferon Therapy

Copyright Sagicor Life Insurance Company. All rights reserved.

Surveillance for Hepatocellular Carcinoma

THE BUSINESS COUNCIL OF WESTCHESTER Website & Internet Services Terms And Conditions of Use

CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA

Long Island IVF Terms and Conditions of Use

Educational Issues Following Treatment for Childhood Cancer

DISCRETE SEMICONDUCTORS DATA SHEET. dbook, halfpage M3D088. BB201 Low-voltage variable capacitance double diode. Product specification 2001 Oct 12

Hepatic Perfusion Abnormalities

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Corporate and Investment Banking. Webtrader Challenge Rules. Play the Global Markets

Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases

TERMS AND CONDITIONS

Terms & Conditions. Introduction. The following terms and conditions govern your use of this website (VirginiaHomeRepair.com).

Optimal imaging surveillance schedules after liver directed therapy for hepatocellular carcinoma

Subcutaneous desmoid tumors: characteristic "sun-burst" appearance on MRI and ultrasound

Glenmeadow, Inc. Terms and Conditions of Use Legal Notices/ Privacy Policy

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

AGREEMENT BETWEEN USER AND DENTAL WARRANTY CORP

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

Terms and Conditions

INTERPRETATION OF BLOOD TESTS FOR LIVER DISEASE

1. Your Acceptance 2. LKIS App Access 3. Intellectual Property Rights 4. Warranty Disclaimer

UK Guidelines for the management of suspected hepatocellular carcinoma (HCC) in adults

Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery

EMEA PUBLIC STATEMENT ON LEFLUNOMIDE (ARAVA) - SEVERE AND SERIOUS HEPATIC REACTIONS -

CENTRAL SAVINGS BANK BUSINESS INTERNET BANKING AGREEMENT

Wireless Subwoofer TI Design Tests

TERMS AND CONDITIONS

GitLab.com Terms GITLAB.COM TERMS

DISCRETE SEMICONDUCTORS DATA SHEET

The child with abnormal liver function tests

This agreement applies to all users of Historica Canada websites and other social media tools ( social media tools or social media channels ).

Sample Customer Reports

Trioptek Solutions, Inc. Terms of Service (TOS) And Hosted Services Agreement

RGS WEBSITE AND SOCIAL MEDIA POLICY. RGS (Regional Government Services Authority) established its first Internet Website Policy in 2015.

Cordova Telephone Cooperative/Cordova Wireless Communications. Internet Service Agreement

BlackBerry Business Cloud Services. Version: Release Notes

TaxSaverNetwork. Terms of Service

Bilirubin (serum, plasma)

Small Pond Web Hosting Terms and Conditions

This document has been provided by the International Center for Not-for-Profit Law (ICNL).

Hepatitis C. Laboratory Tests and Hepatitis C

N staging in non small cell lung cancer (NSCLC): performance of CT, PET-CT and endoscopic ultrasound in comparison with histopathology

Treatment of Hepatic Neoplasm

New Development in Treating Liver Disorders: Approaches to liver function test from mild to fulminant disorders

Hamilton.net User Agreement Revised August 31, Acceptance of Terms Through Use

Online Business Terms and Conditions - A Brief Glossary

State of Utah Version of Document E

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto

EULA. 1.Standard Terms and Conditions:

Multi-Transformer LED TV Power User Guide. Anderson Hsiao

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine

Evaluation and Prognosis of Patients with Cirrhosis

SOCIAL MEDIA THE RECORDS MANAGEMENT CHALLENGE SOCIAL MEDIA AS RECORDS QUESTION

Benign Liver Tumors. Cameron Schlegel PGY-1 3/6/2013

Functional MRI (DCE-MRI) in the follow-up of prostate cancer after beam radiotherapy (EBRT)

HOW TO EVALUATE ELEVATED LIVER ENZYMES

BBC.NET WEB SPACE USER AGREEMENT

New All Oral Therapy for Chronic Hepatitis C Virus (HCV): A Cost-Benefit Analysis

Seton Medical Center Hepatocellular Carcinoma Patterns of Care Study Rate of Treatment with Chemoembolization N = 50

Direct Alloys LLC. An Online Premium Metals Clearinghouse 901 Broad Street Utica, NY Fax

Online Study Affiliate Marketing Agreement

Transcription:

Preoperative evaluation of future remnant liver function by the contrast enhance ratio in hepatocellular image. Poster No.: C-0564 Congress: ECR 2011 Type: Scientific Exhibit Authors: S. Matsushima, Y. Sato, H. Yamaura, M. kato, T. Kanamoto, 1 2 1 2 1 1 1 1 1 1 2 Y. Kinosada, S. Era, H. Koyanagi, Y. Inaba ; Nagoya/JP, Gifu/ JP Keywords: Molecular imaging, Liver, Abdomen, MR, MR-Functional imaging, Contrast agent-other, Safety DOI: 10.1594/ecr2011/C-0564 Any information contained in this pdf file is automatically generated from digital material submitted to EPOS by third parties in the form of scientific presentations. References to any names, marks, products, or services of third parties or hypertext links to thirdparty sites or information are provided solely as a convenience to you and do not in any way constitute or imply ECR's endorsement, sponsorship or recommendation of the third party, information, product or service. ECR is not responsible for the content of these pages and does not make any representations regarding the content or accuracy of material in this file. As per copyright regulations, any unauthorised use of the material or parts thereof as well as commercial reproduction or multiple distribution by any traditional or electronically based reproduction/publication method ist strictly prohibited. You agree to defend, indemnify, and hold ECR harmless from and against any and all claims, damages, costs, and expenses, including attorneys' fees, arising from or related to your use of these pages. Please note: Links to movies, ppt slideshows and any other multimedia files are not available in the pdf version of presentations. www.myesr.org Page 1 of 31

Purpose Preoperative evaluation of future remnant liver (FRL) function is crucial in the determination of whether a patient can safely undergo liver resection. Gd-EOB-DTPA is a newly developed MR contrast agent for hepatocellular imaging; it can be used as a tracer for liver function testing. We reported that the contrast enhance ratio in hepatocellular (CERH) imaging is a potentially useful method for liver function image by MRI. The purpose of this study is to evaluate of FRL function through the CERH imaging using Gd-EOB-DTPA. Images for this section: Fig. 1 Page 2 of 31

Fig. 2 Page 3 of 31

Methods and Materials Design of this study for liver function image. Measurement data are MRI before enhancement, MRI of hepatobiliary phase (post CE 20 min), blood biochemistry data reflecting a liver function, fibrotic stage of liver. The following items were reviewed based on these data. The CERH value was defined as the percentage of signal up between the before contrast enhanced and hepatocellular images. The CERH images are the calculation images which did imaging of CERH value. #The significance between the CERH value and fibrotic stage of the liver. # Relations of CERH and liver function tests. #Threshold of CERH values detecting liver function abnormality. A utility of CERH imeges as liver function images was evaluated from the abovementioned results. Design of this study for FRL function image. Relations of CERH values and Remnant liver K-ICG in FRL. Methods and Material 76 patients with hepatocellular carcinoma were studied. 16 patients were operated for HCC. We adopted the contrast enhanced ratio technique for hepatocellular imaging to evaluate the CERH values. Hepatocellular images were imaged after an intravenous bolus injection of Gd-EOB for 20 minutes. The CERH value was defined as the percentage of signal gain between the before contrast and hepatocellular images. The CERH images were constructed on the basis of the percentage of CERH values. The CERH value measured the whole liver of non-cancer part without hepatocellular carcinoma, and FRL. We used liver function tests such as biochemical tests to determine threshold of CERH for detection of liver function abnormality. Threshold of CERH values detecting liver function abnormality were determined using the two-graph receiver operating characteristic analysis. Images for this section: Page 4 of 31

Fig. 1 Page 5 of 31

Fig. 2 Page 6 of 31

Fig. 3 Page 7 of 31

Fig. 4 Page 8 of 31

Fig. 5 Page 9 of 31

Fig. 6 Page 10 of 31

Fig. 7 Page 11 of 31

Fig. 8 Page 12 of 31

Fig. 9 Page 13 of 31

Results No-fibrotic liver shows a higher CERH value, the CERH image is shown in red. On the other hand, liver cirrhosis shows a lower CERH value, the CERH image is shown in blue (Fig. 1). A statistically significant difference was obtained the CERH values of no fibrotic liver, hepatitis and liver cirrhosis (Table 1). The CERH value related to albumin, AST, ICG-15, PT(%), platelet billirubin, ChE by correlation coefficient (Table 2). A statistically significant difference was obtained the CERH values of fibrotic stage, #-GPT, billirubin, ICG-15, PT(%), platelet, ChE, albumin, LDH (Table 3). Figure 2 shows a correlation between CERH value and ICG-15. The CERH values threshold used to judge the presence of abnormal is predicted to be 121.1 % ( sensitivity 0.83 and specificity 0.89) (Table 4). The good FRL function shows a higher CERH value, the CERH image is shown in red. On the other hand, the poor FRL function shows a lower CERH value, the CERH image is shown in blue (Fig. 4#Fig.6). Figure 7 shows a correlation between CERH value and remnant liver K-ICG in the FRL. The operative safety zone was shown with yellowish green. Images for this section: Page 14 of 31

Fig. 1 Page 15 of 31

Fig. 2 Page 16 of 31

Fig. 3 Page 17 of 31

Fig. 4 Page 18 of 31

Fig. 5 Page 19 of 31

Fig. 6 Page 20 of 31

Fig. 7 Page 21 of 31

Fig. 8 Page 22 of 31

Fig. 9 Page 23 of 31

Fig. 10 Page 24 of 31

Fig. 11 Page 25 of 31

Fig. 12 Page 26 of 31

Fig. 13 Page 27 of 31

Fig. 14 Page 28 of 31

Conclusion ICG examination is considered to be an index of liver residual function. Problems of ICG examination are to evaluate the whole liver function. The CERH value related to liver function tests by correlation coefficient. The threshold of CERH value to judge the abnormal was about 121.1% from liver function tests by the two-graph receiver operating characteristic analysis. In the FRL, the CERH value related to remnant liver K-ICG. These results clarified that CERH values are parameters to show a FRL function, and CERH images are useful as a FRL function imaging to safely undergo liver resection. Images for this section: Fig. 1 Page 29 of 31

Fig. 2 Page 30 of 31

References Remnant liver K-ICG Yasuhiro Kurumiya, MD, Masato Nagino, MD, Katsura Nozawa, MD, Junichi Kamiya, MD, Katsuhiko Uesaka, MD, Tsuyoshi Sano, MD, Shonen Yoshida, MD, and Yuji Nimura, MD, Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer.surgery 2003;133:512-20. Personal Information Page 31 of 31